healthcare

Does Drug Testing for Marijuana Tell Us Anything?

Earlier this month, Quest Diagnostics, the world's leading supplier of diagnostic services, released its 2018 Drug Testing Index reporting results of U.S. employers' 2017 drug-tests. The good news is that ...
Read Full Story »

Amgen Wins Another FDA Approval

Amgen Inc. (NASDAQ: AMGN) shares made a slight gain on Tuesday after it was announced that the U.S. Food and Drug Administration (FDA) approved its treatment of glucocorticoid-induced osteoporosis in ...
Read Full Story »

Dova Pharmaceuticals Slumps Despite FDA Approval

Dova Pharmaceuticals Inc. (NASDAQ: DOVA) shares dropped on Monday following a critical update from the U.S. Food and Drug Administration (FDA) on one of its subsidiaries. Essentially, the agency granted ...
Read Full Story »

Should Nabriva Be Seeing a Better Response for This Positive Trial?

Nabriva Therapeutics PLC (NASDAQ: NBRV) watched its shares take a step back on Monday's despite seeing positive results in its late-stage pneumonia trial. The stock was actually up about 17% ...
Read Full Story »

Medical Marijuana Protection Included in Federal Budget Bill

Last Thursday the House Appropriations Committee attached an amendment to the fiscal year 2019 commerce, justice, and science appropriations bill that would prohibit federal spending to interfere with state medical ...
Read Full Story »

9 Companies Bracing for Big ASCO Reactions

This year marks the 54th annual meeting of the American Society of Clinical Oncology (ASCO). Biotech and pharmaceutical companies will descend on Chicago for a five-day all-out conference (June 1 ...
Read Full Story »

Why Jounce Shares Are Crumbling Ahead of ASCO

Jounce Therapeutics Inc. (NASDAQ: JNCE) watched its shares crumble on Thursday after the firm released data from its midstage cancer trial. This data comes at a pivotal point, not just ...
Read Full Story »

Why Evolus Shares Are Getting Slammed

Evolus Inc. (NASDAQ: EOLS) watched its shares come crashing down on Wednesday after the company announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) ...
Read Full Story »

Are Abaxis Shareholders Getting Enough in the Buyout?

Abaxis Inc. (NASDAQ: ABAX) shares hit an all-time high early on Wednesday after it was announced that Zoetis Inc. (NYSE: ZTS) would be acquiring the firm. The acquisition is expected ...
Read Full Story »

Are Xenon Pharmaceuticals Shares Making a Run?

Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares saw a handy gain on Tuesday after the firm announced positive data from a couple of its trials. Specifically, Xenon presented data from its ...
Read Full Story »

Why Sports Betting Ruling Is a Win for State Marijuana Laws

Monday's six-to-three U.S. Supreme Court ruling in a sports gambling case prevents the federal government from forcing states to enforce federal law. In this case, the law in question was ...
Read Full Story »

Consolidation in Canada’s Marijuana Patch: Aurora to Acquire MedReLeaf

In an all-stock deal valued at C$3.2 billion (about US$2.5 billion), Canadian marijuana grower Aurora Cannabis will acquire MedReLeaf. Both are major Canadian cultivators of cannabis for the medical market, along ...
Read Full Story »

Canadian Marijuana Grower to List on NYSE

Canopy Growth is the largest North American marijuana firm based on its market cap of $4.72 billion. The company's stock currently trades on the Toronto Stock Exchange under the ticker ...
Read Full Story »

The 4 States That Will Vote on Marijuana Initiatives This Year

Sales and possession of marijuana for adult recreational use is legal in nine U.S. states and the District of Columbia. Another 29 states have legalized marijuana for medical use. As ...
Read Full Story »

Oregon Marijuana Market Flooded With Product, Prices Crash

Consumers in the state of Oregon smoked or vaped or otherwise ingested 340,000 pounds of legal cannabis last year. At the same time, Oregon growers produced 1.1 million pounds of ...
Read Full Story »